HIV Infections: all 4,342 studies
Page 34 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIVCompletedNCT00144157Phase 4
- A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.TerminatedNCT00144105Phase 2
- 3TC or No 3TC for HIV With 3TC ResistanceSuspendedNCT00143728Phase 4
- Immunologic Memory (Supp. of ATN 024)CompletedNCT00142753Phase 4
- One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose NevirapineCompletedNCT00142337Phase 2
- Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected AdultsCompletedNCT00141024Phase 1
- Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected PatientsCompletedNCT00140751Phase 3
- Prognosis of Acute Coronary Syndrome in HIV-infected PatientsCompletedNCT00139958
- Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South AfricaCompletedNCT00138047Phase 2
- A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the RegimenCompletedNCT00135447
- Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin MetabolismCompletedNCT00135434Phase 1
- A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART RegimenCompletedNCT00135395Phase 3
- Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based RegimenCompletedNCT00135382Phase 3
- Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily RegimenCompletedNCT00135369Phase 3
- A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing RegimenCompletedNCT00135343Phase 3
- Pediatric Impact: Promoting Adherence to Medications Among HIV-infected ChildrenCompletedNCT00134602Not applicable
- Influence of Chloroquine on HIV Viral Load Among Pregnant Women in UgandaCompletedNCT00132535Not applicable
- Study of UC-781 Vaginal MicrobicideCompletedNCT00132444Phase 1
- A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral TherapyCompletedNCT00131807
- Safety and Efficacy of T Cell Genetic Immunotherapy for HIVStatus unknownNCT00131560Phase 2
- Managed Problem Solving to Increase Treatment Adherence in Individuals With HIVCompletedNCT00130273Not applicable
- Trial of SAVVY Vaginal Gel and HIV in NigeriaStatus unknownNCT00130078Phase 3
- Trial of SAVVY and HIV in GhanaStatus unknownNCT00129532Phase 3
- Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART RegimensCompletedNCT00129194Phase 1
- Sequential HIV Therapy in Treatment Resistant HIV-1 Infected PatientsTerminatedNCT00128908Phase 4
- 2NN & CHARM Long-Term Follow-up StudyCompletedNCT00127972Phase 4
- Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on ChemotherapyTerminatedNCT00127569Phase 2
- AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIVCompletedNCT00126880Phase 2
- Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected WomenCompletedNCT00125983Phase 2
- HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult ParticipantsCompletedNCT00125970Phase 2
- Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral SuppressionTerminatedNCT00125814Phase 3
- Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV InfectionCompletedNCT00125099Phase 1/2
- Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected AdultsCompletedNCT00124007Phase 1
- Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African AdultsCompletedNCT00123968Phase 1/2
- Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140TerminatedNCT00123890Phase 3
- Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in UgandaCompletedNCT00122941Phase 3
- Spirituality and Will to Live in Patients With HIV/AIDSCompletedNCT00122902
- Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive PatientsTerminatedNCT00122668Phase 4
- Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With LipoatrophyTerminatedNCT00122655Phase 4
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis CCompletedNCT00122616Phase 3
- Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)CompletedNCT00122603Phase 2
- Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)TerminatedNCT00122590Not applicable
- Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected PatientsTerminatedNCT00122577Phase 2
- Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy VolunteersTerminatedNCT00122564Phase 1
- Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)TerminatedNCT00122551Phase 3
- Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)CompletedNCT00122538Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVTerminatedNCT00122512Phase 2
- Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIVCompletedNCT00122486Phase 2
- Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV SubjectsCompletedNCT00121979Phase 2
- AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV VolunteersCompletedNCT00121758Phase 2
- Effectiveness of the Diaphragm for HIV PreventionWithdrawnNCT00121459Phase 3
- Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult VolunteersCompletedNCT00121121Phase 1
- Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug ResistanceTerminatedNCT00120783Phase 2
- Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)CompletedNCT00120757Phase 3
- Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their BabiesCompletedNCT00120471Phase 1
- Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)Status unknownNCT00120419Phase 4
- Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/RitonavirCompletedNCT00120393Phase 3
- Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)CompletedNCT00120367Phase 2
- Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)CompletedNCT00120185Phase 2
- Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsCompletedNCT00119873Phase 1
- Home-based AIDS Care ProjectTerminatedNCT00119093Not applicable
- Long-Term Supervised Treatment Interruption in HIV-Infected PatientsCompletedNCT00118677Phase 3
- Pediatric Nevirapine Resistance StudyStatus unknownNCT00117728Phase 3
- Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)CompletedNCT00117494Phase 4
- Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult PatientsCompletedNCT00116636Phase 2
- DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyCompletedNCT00116415Not applicable
- Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)CompletedNCT00116298Phase 3
- DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral TherapyCompletedNCT00116116Phase 4
- Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected AdultsCompletedNCT00115960Phase 1
- Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV TransmissionCompletedNCT00115648Phase 3
- Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)CompletedNCT00115609Phase 3
- TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment OptionsCompletedNCT00115050Phase 3
- "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV SubjectsCompletedNCT00114933Phase 4
- Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral TherapyCompletedNCT00114699Phase 1
- A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected PatientsStatus unknownNCT00113412Phase 2
- Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)CompletedNCT00113282Phase 2
- Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV InfectionCompletedNCT00113126Not applicable
- Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected AdultsCompletedNCT00111605Phase 1
- Study of Home-Based Resistance and Strength Training in HIV-Infected WomenCompletedNCT00111332Not applicable
- TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 TrialCompletedNCT00111280Phase 2
- Botswana Tenofovir Oral HIV Prophylaxis TrialTerminatedNCT00111150Phase 2/3
- TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced PatientsCompletedNCT00110877Phase 3
- Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected AdultsCompletedNCT00110578Phase 1
- "Prime-Boost" Vaccine Schedule for Prevention of HIV InfectionCompletedNCT00109629Phase 1
- Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable TherapyCompletedNCT00107549Phase 1
- Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ YouthCompletedNCT00107029
- Typology of Adherence in Adolescents: Phase IICompletedNCT00106678
- Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 PatientsCompletedNCT00106379Phase 4
- Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral TreatmentCompletedNCT00105417Phase 1
- Computer-Generated Vs. Standard Informed Consent for HIV Research StudiesStatus unknownNCT00104559Not applicable
- GW873140 In Combination With Combivir In HIV Infected SubjectsTerminatedNCT00104429Phase 2
- An Observational Study of People Who Have Recently Been Infected With HIVCompletedNCT00103961
- Connect to Protect Partnerships for Youth Prevention Interventions: Phase IICompletedNCT00103896
- A Novel Method to Determine HIV Incidence Among YouthCompletedNCT00103883
- Healthy Choices to Promote Health and Reduce Risk in HIV-Infected YouthCompletedNCT00103532Not applicable
- Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and WomenCompletedNCT00102986Not applicable
- Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant VirusStatus unknownNCT00102934Not applicable
- GW873140 In Combination With Kaletra In HIV Infected SubjectsTerminatedNCT00102778Phase 2
- A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior TherapyCompletedNCT00102206Phase 2
- HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult VolunteersCompletedNCT00102089Phase 1